Evaluating Treatment Response in CIDP: Clinical Precision in a Heterogeneous Disorder
Evaluation of treatment efficacy in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is inherently challenging. This complexity reflects the marked biological and clinical heterogeneity of the disorder, as well as the substantial placebo response consistently reported in clinical trials.
Relateret indhold
Brænder du for at skrive?
Vil du gerne dele din forskning eller dine kliniske erfaringer med dine kollegaer inden for netop dit speciale? Har du en ide til en artikel, som du gerne vil udgive hos os? Send redaktionen en mail på redaktion@bpno.dk
Send mail til redaktionen